Baltimore settles opioid marketing lawsuit against Johnson & Johnson, amount undisclosed.

Baltimore has settled its lawsuit against Johnson & Johnson over opioid marketing allegations just before a trial was set to begin. The settlement amount remains undisclosed, contrasting with previous settlements that were publicly shared. Baltimore is still pursuing cases against other firms, including McKesson and Purdue Pharma. The city has allocated $20 million for its health department and $42 million for organizations addressing substance abuse from prior settlements.